Zimmer Biomet Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones

2025.12.01 22:07

I'm PortAI, I can summarize articles.

Zimmer Biomet Holdings Inc. (ZBH) shares fell 2.83% to $94.76 on Monday, underperforming compared to competitors like Johnson & Johnson and Medtronic. The stock is 17.20% below its 52-week high of $114.44. Trading volume was 2.6 million, surpassing the 50-day average of 1.8 million. The decline occurred during a generally poor trading session, with the S&P 500 and Dow Jones also falling.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Zimmer Biomet Holdings Inc. (ZBH) slid 2.83% to $94.76 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. This was the stock's second consecutive day of losses. Zimmer Biomet Holdings Inc. closed 17.20% short of its 52-week high of $114.44, which the company reached on April 3rd. The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.76% to $205.34, Medtronic PLC (MDT) fell 1.89% to $103.34, and Stryker Corp. (SYK) rose 0.31% to $372.32. Trading volume (2.6 M) eclipsed its 50-day average volume of 1.8 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1707ET